Deal involves agreement with Regeneron to lower costs for Medicaid
President Donald Trump on Thursday announced a new program to cut the costs of pharmaceuticals for consumers, a problem he repeatedly has worked to address while in the White House.
The new plan, according to a report from legacy wire service AP, is that drugmaker Regeneron will lower the cost of its products to comply with the president’s drug price cutting agenda.
“The deal involves Regeneron lowering the prices of current and all future drugs on Medicaid, according to Trump. It also involves selling a cholesterol drug called Praluent for $225 on the White House’s discounted drug website TrumpRx, according to the agreement first outlined by NOTUS and confirmed by White House press secretary Karoline Leavitt,” the report said.